Skip to main content

Clinical and Practical Recommendations in the Use of Exercise, Physical Therapy, and Occupational Therapy for Chemotherapy-Induced Peripheral Neuropathy

  • Chapter
  • First Online:
Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent, severe, and dose-limiting toxicity of several chemotherapy regimens for the treatment of multiple cancers including lung, breast, prostate, gastrointestinal, blood, and others. Patients with CIPN may experience numbness, tingling, pain, and cramping in the hands and feet, as well as problems with balance and gait that increase the risk of falls, reduce physical function, and hinder activities of daily living. At this point there are extremely limited treatment options for CIPN. Fortunately, a growing body of preliminary evidence suggests that exercise, physical therapy, and occupational therapy may help prevent, treat, and manage CIPN. Although there is not definitive evidence for the benefits of exercise on CIPN due to lack of Phase III randomized controlled trials, exercise is generally helpful in the cancer treatment continuum and poses low risk for patients with the help of a qualified professional. Therefore, we present clinical suggestions in the use of exercise for CIPN, including assessments of patient risk factors and other considerations. We conclude with an example exercise prescription that a qualified exercise professional can adapt for the specific needs, risks, and abilities of each individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470. https://doi.org/10.1016/j.pain.2014.09.020

    Article  PubMed  Google Scholar 

  2. Chan A, Hertz DL, Morales M, Adams EJ, Gordon S, Tan CJ et al (2019) Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview. Support Care Cancer:1–9. https://pubmed.ncbi.nlm.nih.gov/31363906/

  3. Staff NP, Grisold A, Grisold W, Windebank AJ (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772–781. https://doi.org/10.1002/ana.24951

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Gu Y, Menzies AM, Long GV, Fernando S, Herkes G (2017) Immune mediated neuropathy following checkpoint immunotherapy. J Clin Neurosci 45:14–17

    Article  PubMed  Google Scholar 

  5. Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A et al (2012) Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: north central Cancer treatment group trial N08C1. Cancer 118(20):5171–5178

    Article  PubMed  Google Scholar 

  6. Argyriou AA, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M et al (2013) Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer 119(2):438–444

    Article  CAS  PubMed  Google Scholar 

  7. Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE et al (2015) Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance). J Clin Oncol 33(30):3416

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM et al (2018) Two-year trends of Taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-L- carnitine (SWOG S0715). J Natl Cancer Inst 110(6):669–676. https://doi.org/10.1093/jnci/djx259

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bandos H, Melnikow J, Rivera DR, Swain SM, Sturtz K, Fehrenbacher L et al (2018) Long-term peripheral neuropathy in breast cancer patients treated with adjuvant chemotherapy: NRG oncology/NSABP B-30. J Natl Canc Inst 110(2):djx162. https://doi.org/10.1093/jnci/djx162

    Article  Google Scholar 

  10. daCosta DBM, Copher R, Basurto E, Faria C, Lorenzo R (2014) Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer. Am Health Drug Benefits 7(7):386–396

    Google Scholar 

  11. Lyman GH (2009) Impact of chemotherapy dose intensity on cancer patient outcomes. Journal of the National Comprehensive Cancer Network : JNCCN 7(1):99–108

    Article  PubMed  Google Scholar 

  12. Gewandter JS, Kleckner AS, Marshall JH, Brown JS, Curtis LH, Bautista J et al (2019) Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data. Support Care Cancer:1–10. https://pubmed.ncbi.nlm.nih.gov/31494735/

  13. Pike CT, Birnbaum HG, Muehlenbein CE, Pohl GM, Natale RB (2012) Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemother Res Pract 2012:913848. https://doi.org/10.1155/2012/913848

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chan CW, Cheng H, Au SK, Leung KT, Li YC, Wong KH et al (2018) Living with chemotherapy- induced peripheral neuropathy: uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors. Eur J Oncol Nurs 36:135–141

    Article  PubMed  Google Scholar 

  15. Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ et al (2017) Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast Cancer Res Treat 164(1):69–77. https://doi.org/10.1007/s10549-017-4230-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wasilewski A, Mohile N (2020) Meet the expert: how I treat chemotherapy-induced peripheral neuropathy. J Geriatr Oncol. https://doi.org/10.1016/j.jgo.2020.06.008

  17. Kolb NA, Smith AG, Singleton JR, Beck SL, Stoddard GJ, Brown S et al (2016) The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the risk of falling. JAMA Neurol 73(7):860–866. https://doi.org/10.1001/jamaneurol.2016.0383

    Article  PubMed  PubMed Central  Google Scholar 

  18. Gewandter JS, Fan L, Magnuson A, Mustian K, Peppone L, Heckler C et al (2013) Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Supportive Care Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 21(7):2059–2066. https://doi.org/10.1007/s00520-013-1766-y

    Article  CAS  Google Scholar 

  19. Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 38(28):3325–3348. https://doi.org/10.1200/JCO.20.01399

    Article  PubMed  Google Scholar 

  20. Brami C, Bao T, Deng G (2016) Natural products and complementary therapies for chemotherapy- induced peripheral neuropathy: a systematic review. Crit Rev Oncol Hematol 98:325–334. https://doi.org/10.1016/j.critrevonc.2015.11.014

    Article  PubMed  Google Scholar 

  21. Dorsey SG, Kleckner IR, Barton D, Mustian K, O'Mara A, St Germain D et al (2019) NCI clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djz011

  22. Duregon F, Vendramin B, Bullo V, Gobbo S, Cugusi L, Di Blasio A et al (2018) Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: a systematic review. Crit Rev Oncol Hematol 121:90–100. https://doi.org/10.1016/j.critrevonc.2017.11.002

    Article  PubMed  Google Scholar 

  23. Kanzawa-Lee GA, Larson JL, Resnicow K, Smith EML (2020) Exercise effects on chemotherapy- induced peripheral neuropathy: a comprehensive integrative review. Cancer Nurs 43(3):E172–EE85

    Article  PubMed  Google Scholar 

  24. Kleckner IR, Park SB, Streckmann F, Wiskemann J, Hardy S, Mohile NA (2021) Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy. In: Lustberg MB, Loprinzi CL (eds) Diagnosis, management and emerging strategies for chemotherapy induced neuropathy. Springer, Berlin

    Google Scholar 

  25. Campbell KL, Weller S, Cormie P, Lane KN, Rauw JM, Goulart J (2020) Enhancing safety of exercise for individuals with bone metastases: screening recommendations developed through Delphi consensus process. Am Soc Clin Oncol. https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e24042

  26. Campbell KL, Neil SE, Winters-Stone KM (2012) Review of exercise studies in breast cancer survivors: attention to principles of exercise training. Br J Sports Med 46(13):909–916

    Article  PubMed  Google Scholar 

  27. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS et al (2019) Exercise guidelines for Cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51(11):2375–2390. https://doi.org/10.1249/MSS.0000000000002116

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C et al (2018) Exercise for toxicity management in cancer—a narrative review. Oncology & hematology review 14(1):28

    Google Scholar 

  29. Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG et al (2012) Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients. Support Care Cancer 20(10):2433–2439

    Article  PubMed  Google Scholar 

  30. Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V et al (2012) Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer 118(S8):2207–2216

    Article  PubMed  Google Scholar 

  31. Caspersen CJ, Powell KE, Christenson GM (1985) Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 100(2):126–131

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Wasfy MM, Baggish AL (2016) Exercise dose in clinical practice. Circulation 133(23):2297–2313

    Article  PubMed  PubMed Central  Google Scholar 

  33. Neil-Sztramko SE, Medysky ME, Campbell KL, Bland KA, Winters-Stone KM (2019) Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review. BMC Cancer 19(1):321

    Article  PubMed  PubMed Central  Google Scholar 

  34. Kenjale AA, Hornsby WE, Crowgey T, Thomas S, Herndon JE (2014) Pre-exercise participation cardiovascular screening in a heterogeneous cohort of adult cancer patients. Oncologist 19(9):999

    Article  PubMed  PubMed Central  Google Scholar 

  35. American College of Sports Medicine (2017) ACSM’s guidelines for exercise testing and prescription. Lippincott, Williams, & Wilkins, Baltimore, MD

    Google Scholar 

  36. Cole CL, Kleckner IR, Jatoi A, Schwarz EM, Dunne RF (2018) The role of systemic inflammation in cancer-associated muscle wasting and rationale for exercise as a therapeutic intervention. JCSM Clin Rep 3(2):1–19

    Google Scholar 

  37. Wolin KY, Schwartz AL, Matthews CE, Courneya KS, Schmitz KH (2012) Implementing the exercise guidelines for cancer survivors. J Support Oncol 10(5):171

    Article  PubMed  PubMed Central  Google Scholar 

  38. Streckmann F, Balke M (2018) Bewegungstherapie bei Polyneuropathie. DGNeurologie 1(1):47–57

    Article  Google Scholar 

  39. Carayol M, Bernard P, Boiche J, Riou F, Mercier B, Cousson-Gélie F et al (2013) Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed? Ann Oncol 24(2):291–300

    Article  CAS  PubMed  Google Scholar 

  40. Boutcher SH (1993) Emotion and aerobic exercise. In: Singer RN, Murphey M, Tennant LK (eds) Handbook of research on sport psychology. Macmillan, New York, pp 799–814

    Google Scholar 

  41. Worthen-Chaudhari L, Lamantia MT, Monfort SM, Mysiw W, Chaudhari AMW, Lustberg MB (2019) Partnered, adapted argentine tango dance for cancer survivors: a feasibility study and pilot study of efficacy. Clin Biomech (Bristol, Avon) 70:257–264. https://doi.org/10.1016/j.clinbiomech.2019.08.010

    Article  CAS  Google Scholar 

  42. Schwenk M, Grewal GS, Holloway D, Muchna A, Garland L, Najafi B (2016) Interactive sensor- based balance training in older Cancer patients with chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Gerontology 62(5):553–563. https://doi.org/10.1159/000442253

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the following funding mechanisms to support this work, including the National Cancer Institute K07CA221931 to IRK, a National Health and Medical Research Council of Australia Career Development Fellowship (#1148595) to SBP. The authors also thank the Transdisciplinary Research in Energetics and Cancer (TREC) Training Workshop funded by the National Cancer Institute (R25CA203650) and the Multinational Association for Supportive Care in Cancer (MASCC) for facilitating collaboration among the authors. The authors also thank Dr. Amber Kleckner for editorial input.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian R. Kleckner .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kleckner, I.R., Park, S.B., Streckmann, F., Wiskemann, J., Hardy, S., Mohile, N. (2021). Clinical and Practical Recommendations in the Use of Exercise, Physical Therapy, and Occupational Therapy for Chemotherapy-Induced Peripheral Neuropathy. In: Lustberg, M., Loprinzi, C. (eds) Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy. Springer, Cham. https://doi.org/10.1007/978-3-030-78663-2_9

Download citation

Publish with us

Policies and ethics